Header placeholder lorem ipsum dolor sit amet, consectetur adipiscing elit.

Annual Revenue ()

Boehringer Ingelheim revenue was €20.62 b in FY, 2021

FY, 2019FY, 2020FY, 2021
Revenue€19 b€19.57 b€20.62 b

Revenue Breakdown

Business Segment

Geographic Segment

Boehringer Ingelheim revenue breakdown by business segment: 20.8% from Animal Health, 74.2% from Human Pharmaceuticals and 5.0% from Other

Boehringer Ingelheim revenue breakdown by geographic segment: 44.4% from Americas, 23.8% from Asia/Australia/Africa and 31.8% from Europe

FY, 2019FY, 2020FY, 2021
Animal Health€4.04 b€4.12 b€4.3 b
Biopharmaceuticals€786 m€837 m€917 m
Discontinued Operations€174 m€160 m€79 m
Human Pharmaceuticals€13.96 b€14.42 b€15.29 b
Other sales€41 m€33 m€33 m
FY, 2019FY, 2020FY, 2021
Americas€8.83 b€8.89 b€9.15 b
Asia/Australia/Africa€4.48 b€4.8 b€4.92 b
Europe€5.69 b€5.88 b€6.55 b

Need Data?

Craft can deliver 250+ data points of financial, operating, and human capital indicators on companies via API.

Footer menu